Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions

Journal of Steroid Biochemistry and Molecular Biology

Volumn 69, Issue 1-6, 1999, Pages 3-12

  McKenna, Neil J ^a   Xu, Jianming ^a   Nawaz, Zafar ^a   Tsai, Sophia Y ^a   Tsai, Ming Jer ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coactivators; Enzymes; Nuclear receptors; Proteins

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL NUCLEUS RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENZYME; HISTONE ACETYLTRANSFERASE; HORMONE RECEPTOR; PROTEIN; PROTEIN P53; RETINOID; RNA POLYMERASE II; STEROID HORMONE; TATA BINDING PROTEIN; THYROID HORMONE; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE;

CHROMATIN; COMPLEX FORMATION; CONFERENCE PAPER; GENE; GENE EXPRESSION; HUMAN; NONHUMAN; TRANSCRIPTION INITIATION;

ANIMALS; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRESSOR PROTEINS; TRANS-ACTIVATORS;

EID: 0033051731     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00144-7     Document Type: Conference Paper

References (92)

1. Tsai M.J., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
2. Zawel L., Reinberg D. Common themes in assembly and function of eukaryotic transcription complexes. Annu. Rev. Biochem. 64:1995;533-561.
3. Tora L., White J., Brou C., Tasset D., Webster N., Scheer E., Chambon P. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 59:1989;477-487.
4. Meyer M.E., Gronemeyer H., Turcotte B., Bocquel M.T., Tasset D., Chambon P. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell. 57:1989;433-442.
5. O.M. Conneely, D.M. Kettelberger, M.-J. Tsai, B. W. O'Malley, in: A. K. Roy and J. Clark (Eds.), Gene Regulation by Steroid Hormones, Vol. IV, Springer-Verlag, New York, 1989, pp. 220-231.
6. Jacq X., Brou C., Lutz Y., Davidson I., Chambon P., Tora L. Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell. 79:1994;107-117.
7. May M., Mengus G., Lavigne A.C., Chambon P., Davidson I. Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors. EMBO J. 15:1996;3093-3104.
8. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C., Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science. 264:1994;1455-1458.
9. Eggert M., Mows C.C., Tripier D., Arnold R., Michel J., Nickel J., Schmidt S., Beato M., Renkawitz R. A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro. J. Biol. Chem. 270:1995;30755-30759.
10. Cavailles V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P.J., Parker M.G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14:1995;3741-3751.
11. Treuter E., Albrektsen T., Johansson L., Leers J., Gustafsson J.A. A regulatory role for RIP140 in nuclear receptor activation. Mol. Endocrinol. 12:1998;864-881.
12. Le Douarin B., Zechel C., Garnier J.-M., Lutz Y., Tora L., pierrrat B., Heery D., Gronemeyer H., Chambon P., Losson R. The N-terminal part of TIF-1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14:1995;2020-2033.
13. Lee J.W., Ryan F., Swaffield J.C., Johnston S.A., Moore D.D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature. 374:1995;91-94.
14. Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
15. Onate S.A., Boonyaratanakornkit V., Spencer T.E., Tsai S.Y., Tsai M.J., Edwards D.P., O'Malley B.W. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J. Biol. Chem. 273:1998;12101-12108.
16. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 85:1996;403-414.
17. Voegel J.J., Heine M.J., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:1996;3667-3675.
18. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 387:1997;677-684.
19. Hong H., Kohli K., Trivedi A., Johnson D.L., Stallcup M.R. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. U.S.A. 93:1996;4948-4952.
20. Hong H., Kohli K., Garabedian M.J., Stallcup M.R. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell Biol. 17:1997;2735-2744.
21. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 387:1997;677-684.
22. Li H., Gomes P.J., Chen J.D. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. U.S.A. 94:1997;8479-8484.
23. Chen H., Lin R., Schiltz L., Chakravarti D., Nash A., Nagy L., Privalsky M., Nakatani Y., Evans R. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with PCAF and CBP/p300. Cell. 90:1997;569-580.
24. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:1997;965-968.
25. Takeshita A., Cardona G.R., Koibuchi N., Suen C.-S., Chin W.W. TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule exhibits distinct properties from steroid receptor coactivator-1. J. Biol. Chem. 272:1997;27629-27634.
26. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35:1995;307-340.
27. Pongratz I., Antonsson C., Whitelaw M.L., Poellinger L. Role of the PAS domain in regulation of dimerization and DNA binding specificity of the dioxin receptor. Mol. Cell Biol. 18:1998;4079-4088.
28. N.J. McKenna, Z. Nawaz, S.Y. Tsai, M.-J. Tsai, B.W. O'Malley, Distinct steady state nuclear hormone receptor coregulator complexes exist in vivo. Proc. Natl. Acad. Sci. U.S.A., 95 (1998) 11697-11702.
29. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736.
30. Ding X.F., Anderson C.M., Ma H., Hong H., Uht R.M., Kushner P.J., Stallcup M.R. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP-1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 12:1998;302-313.
31. Feng W., Ribeiro R.C., Wagner R.L., Nguyen H., Apriletti J.W., Fletterick R.J., Baxter J.D., Kushner P.J., West B.L. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science. 280:1998;1747-1749.
32. Kwok R.P., Lundblad J.R., Chrivia J.C., Richards J.P., Bachinger H.P., Brennan R.G., Roberts S.G., Green M.R., Goodman R.H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature. 370:1994;223-226.
33. Bhattacharya S., Eckner R., Grossman S., Oldread E., Arany Z., D'Andrea A., Livingston D.M. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α Nature. 383:1996;344-347.
34. Gu W., Shi X.L., Roeder R.G. Synergistic activation of transcription by CBP and p53. Nature. 387:1997;819-823.
35. Lill N.L., Grossman S.R., Ginsberg D., DeCaprio J., Livingston D.M. Binding and modulation of p53 by p300/CBP coactivators. Nature. 387:1997;823-827.
36. Kee B.L., Arias J., Montminy M.R. Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator. J. Biol. Chem. 271:1996;2373-2375.
37. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montminy M., Evans R.M. Role of CBP/p300 in nuclear receptor signalling. Nature. 383:1996;99-103.
38. Smith C.L., Onate S.A., Tsai M.J., O'Malley B.W. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc. Natl. Acad. Sci. U.S.A. 93:1996;8884-8888.
39. Wolffe A.P., Pruss D. Targeting chromatin disruption: transcription regulators that acetylate histones. Cell. 84:1996;817-819.
40. Brownell J.E., Allis C.D. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev. 6:1996;176-184.
41. Brownell J.E., Zhou J., Ranalli T., Kobayashi R., Edmondson D.G., Roth S.Y., Allis C.D. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell. 84:1996;843-851.
42. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 384:1996;641-643.
43. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959.
44. Yang X.J., Ogryzko V.V., Nishikawa J., Howard B.H., Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature. 382:1996;319-324.
45. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J.X., Mizzen C.A., McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.-J., O'Malley B.W. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature. 389:1997;194-198.
46. Jenster G., Spencer T., Burcin M., Tsai S., Tsai M.-J., O'Malley B.W. Steroid receptor induction of gene transcription: a two-step model. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7879-7884.
47. Cairns B.R., Kim Y.J., Sayre M.H., Laurent B.C., Kornberg R.D. A multisubunit complex containing the SWI1/ADR6, SWI2/SNF2, SWI3, SNF5 and SNF6 gene products isolated from yeast. Proc. Natl. Acad. Sci. U.S.A. 91:1994;1950-1954.
48. Peterson C.L., Dingwall A., Scott M.P. Five SWI/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2905-2908.
49. Imbalzano A.N., Kwon H., Green M.R., Kingston R.E. Facilitated binding of TATA-binding protein to nucleosomal DNA. Nature. 370:1994;481-485.
50. Wang W., Cote J., Xue Y., Zhou S., Khavari P.A., Biggar S.R., Muchardt C., Kalpana G.V., Goff S.P., Yaniv M., Workman J.L., Crabtree G.R. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J. 15:1996;5370-5382.
51. Muchardt C., Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J. 12:1993;4279-4290.
52. Chiba H., Muramatsu M., Nomoto A., Kato H. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucl. Acids Res. 22:1994;1815-1820.
53. Ichinose H., Garnier J.M., Chambon P., Losson R. Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2. Gene. 188:1997;95-100.
54. Ostlund Farrants A.K., Blomquist P., Kwon H., Wrange O. Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex. Mol. Cell Biol. 17:1997;895-905.
55. Laurent B.C., Treich I., Carlson M. The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation. Genes Dev. 7:1993;583-591.
56. Fryer C.J., Archer T.K. Chromatin remodelling by the glucocorticoid receptor requires the BRG-1 complex. Nature. 393:1998;88-91.
57. J. DiRenzo, S. Sif, M. Phelan, T.-P. Yao, M. Yancisin, J.A. DeCaprio, R.E. Kingston, M. Brown, in: Keystone Symposium on the Nuclear Receptor Gene Family. Lake Tahoe, NV, 1998.
58. Imhof M.O., McDonnell D.P. Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Mol. Cell Biol. 16:1996;2594-2605.
59. Blanco J.C., Minucci S., Lu J., Yang X.-J., Walker K., Chen H., Evans R.M., Nakatani Y., Ozato K. The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev. 12:1998;1638-1651.
60. Yao T.P., Ku G., Zhou N., Scully R., Livingston D.M. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl. Acad. Sci. U.S.A. 93:1996;10626-10631.
61. Korzus E., Torchia J., Rose D.W., Xu L., Kurokawa R., McInerney E., Mullen T.-M., Glass C.K., Rosenfeld M.G. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science. 279:1998;703-707.
62. Wong J., Shi Y.B., Wolffe A.P. Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: hormone-regulated chromatin disruption is not sufficient for transcriptional activation. EMBO J. 16:1997;3158-3171.
63. Kraus W.L., Kadonaga J.T. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Gene Dev. 12:1998;331-342.
64. Yuan C.X., Ito M., Fondell J.D., Fu Z.Y., Roeder R.G. The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl. Acad. Sci. U.S.A. 95:1998;7939-7944.
65. Fondell J.D., Ge H., Roeder R.G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sci. U.S.A. 93:1996;8329-8333.
66. Rachez C., Suldan Z., Ward J., Chang C.P., Burakov D., Erdjument-Bromage H., Tempst P., Freedman L.P. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev. 12:1998;1787-1800.
67. P.M. Loria, G.L. Greene, in: Nuclear Receptor Gene Family. Lake Tahoe, NV, U.S.A., 1998.
68. Baniahmad A., Kohne A.C., Renkawitz R. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J. 11:1992;1015-1023.
69. Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor. Proc. Natl. Acad. Sci. U.S.A. 93:1996;12195-12199.
70. Baniahmad A., Leng X., Burris T.P., Tsai S.Y., Tsai M.J., O'Malley B.W. The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell Biol. 15:1995;76-86.
71. Seol W., Choi H.S., Moore D.D. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9:1995;72-85.
72. Seol W., Mahon M.J., Lee Y.K., Moore D.D. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol. Endocrinol. 10:1996;1646-1655.
73. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Soderstrom M., Glass C.K.et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 377:1995;397-404.
74. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 377:1995;454-457.
75. Smith C.L., Nawaz Z., O'Malley B.W. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol. Endocrinol. 11:1997;657-666.
76. Jackson T.A., Richer J.K., Bain D.L., Takimoto G.S., Tung L., Horwitz K.B. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. Mol. Endocrinol. 11:1997;693-705.
77. Shibata H., Nawaz Z., Tsai S.Y., O'Malley B.W., Tsai M.J. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT). Mol. Endocrinol. 11:1997;714-724.
78. Zamir I., Harding H.P., Atkins G.B., Horlein A., Glass C.K., Rosenfeld M.G., Lazar M.A. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol. Cell. Biol. 16:1996;5458-5465.
79. Crawford P.A., Dorn C., Sadovsky Y., Milbrandt J. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell Biol. 18:1998;2949-2956.
80. Rundlett S.E., Carmen A.A., Kobayashi R., Bavykin S., Turner B.M., Grunstein M. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14503-14508.
81. Taunton J., Hassig C.A., Schreiber S.L. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science. 272:1996;408-411.
82. Vidal M., Strich R., Esposito R.E., Gaber R.F. RPD1 (SIN3/UME4) is required for maximal activation and repression of diverse yeast genes. Mol. Cell Biol. 11:1991;6306-6316.
83. Wang H., Clark I., Nicholson P.R., Herskowitz I., Stillman D.J. The Saccharomyces cerevisiae SIN3 gene, a negative regulator of HO, contains four paired amphipathic helix motifs. Mol. Cell Biol. 10:1990;5927-5936.
84. Wang H., Stillman D.J. Transcriptional repression in Saccharomyces cerevisiae by a SIN3-LexA fusion protein. Mol. Cell Biol. 13:1993;1805-1814.
85. Nawaz Z., Baniahmad C., Burris T.P., Stillman D.J., O'Malley B.W., Tsai M.J. The yeast SIN3 gene product negatively regulates the activity of the human progesterone receptor and positively regulates the activities of GAL4 and the HAP1 activator. Mol. Gen. Genet. 245:1994;724-733.
86. Heinzel T., Lavinsky R.M., Mullen T.M., Soderstrom M., Laherty C.D., Torchia J., Yang W.M., Brard G., Ngo S.D., Davie J.R., Seto E., Eisenman R.N., Rose D.W., Glass C.K., Rosenfeld M.G. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature. 387:1997;43-48.
87. Nagy L., Kao H.Y., Chakravarti D., Lin R.J., Hassig C.A., Ayer D.E., Schreiber S.L., Evans R.M. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell. 89:1997;373-380.
88. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E., Eisenman R.N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell. 89:1997;349-356.
89. Alland L., Muhle R., Hou H. Jr., Potes J., Chin L., Schreiber-Agus N., DePinho R.A. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature. 387:1997;49-55.
90. Wade P.A., Jones P.L., Vermaak D., Wolffe A.P. A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Curr. Biol. 8:1998;843-846.
91. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Strouboulis J., Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:1998;187-191.
92. Li H., Chen J.D. The receptor-associated coactivator-3 activated transcription through CREB-binding protein recruitment and autoregulation. J. Biol. Chem. 273:1998;5948-5954.